5. NxThera Publishes Rezum II Clinical Study Results on BPH Symptoms
NxThera, Inc., a therapeutic device company responsible for the development of the Convective Water Vapor Energy (WAVE) technology platform for the treatment of Benign Prostatic Hyperplasia (BPH), has published the results from its Rezūm II study. The data from the first year of this multicenter study, revealing the results of transurethral prostate convective water vapor thermal energy treatment of lower urinary tract symptoms (LUTS) secondary to BPH, was published online in The Journal of Urology.
